Pharm-Olam LLC announces the promotion of Natalie Gassen to the position of Chief Financial Officer.
DECEMBER 20, 2015
Pharm-Olam International Ltd., a multi-national, full-service Clinical Research Solutions Organization to the biopharmaceutical and medical device industries, is proud to announce the promotion of Natalie Gassen to the position of Chief Financial Officer.
Natalie brings to Pharm-Olam over 20 years of financial leadership experience in both private and public companies. Prior to coming to Pharm-Olam, Natalie was the Chief Financial Officer for ApoCell, Inc., a molecular biomarker company, and has previously worked in roles with progressing responsibility in several industries including banking, manufacturing, technology, and service businesses.
Sanjiv Suri, Pharm-Olam’s Chief Executive Officer (USA), commented, “We are very fortunate to have Natalie as part of the Pharm-Olam team. Natalie started with Pharm-Olam as the Director of Global Finance and Accounting, and quickly proved that she was the right person to lead Pharm-Olam’s Finance department at a higher level. Natalie has introduced new systems and processes that will allow us to better serve both our internal and external customers.”
For more information about Pharm-Olam, contact info@pharm-olam.com (link sends e-mail)
About Pharm-Olam International Group
Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, Pharm-Olam focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines. Click here to read more.